Effect of sodium-glucose cotransporter-2 inhibitors on pulmonary arterial wedge pressure

Eur J Intern Med. 2024 Jun:124:147-149. doi: 10.1016/j.ejim.2024.03.003. Epub 2024 Mar 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Benzhydryl Compounds / adverse effects
  • Benzhydryl Compounds / therapeutic use
  • Canagliflozin / adverse effects
  • Canagliflozin / therapeutic use
  • Diabetes Mellitus, Type 2 / drug therapy
  • Female
  • Glucosides / adverse effects
  • Glucosides / therapeutic use
  • Humans
  • Hypertension, Pulmonary / drug therapy
  • Male
  • Middle Aged
  • Pulmonary Wedge Pressure* / drug effects
  • Sodium-Glucose Transporter 2 Inhibitors* / adverse effects
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Glucosides
  • Benzhydryl Compounds
  • Canagliflozin